What is BBNX's price / sales?

BBNX (BBNX) reported price / sales of 4× in Q1 2026.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

BBNX BBNX Price / sales

Price / sales at other companies

InsuletPODD

5.1×-3.3×

Tandem Diabetes CareTNDM

1.3×0.0×

MedtronicMDT

2.9×-0.4×

AdaptHealthAHCO

0.5×0.0×

Halozyme TherapeuticsHALO

5.1×-2.2×

Other financials

Income statement

See full

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

See full

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

See full

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

See full

Market cap$708.98M-8.6%

Enterprise value$685.68M—

Profitability

See full

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

See full

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Calculated from BBNX’s reported figures.

market cap/total revenue=4×

Based on the most recent quarter.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BBNX's price / sales?: BBNX (BBNX) reported price / sales of 4× in Q1 2026.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.